# Clinical and genetic features of hereditary transthyretin amyloidosis with polyneuropathy in China: insights from case analysis and literature review

**Authors:** Xiaoyang Yuan, Yajun Lv, Xue Wang, Bing Han, Bingchuan Xie

PMC · DOI: 10.3389/fgene.2026.1715134 · Frontiers in Genetics · 2026-02-19

## TL;DR

This study explores the clinical and genetic features of a rare inherited disease in China and emphasizes the need for comprehensive diagnostic methods.

## Contribution

The study expands the understanding of ATTRv-PN in China and highlights variability in amyloid detection in nerve biopsies.

## Key findings

- Two Chinese patients with ATTRv-PN presented with distinct TTR gene variants and similar neurological symptoms.
- Subclinical cardiac issues were identified in both patients, including valvular and ventricular abnormalities.
- Amyloid detection in nerve biopsies showed no significant correlation with age at disease onset.

## Abstract

Hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) is a progressive multisystem disorder caused by pathogenic TTR variants. Aim of this study is to delineate the clinical and genetic feature of ATTRv-PN in China and to evaluate diagnostic strategies for earlier and accurate recognition.

We investigated two genetically confirmed Chinese patients with ATTRv-PN through comprehensive assessments, including electrophysiology, sural nerve biopsy, autonomic testing, cardiac imaging, neuroimaging, and cerebrospinal fluid analysis. Additionally, logistic regression was performed on 70 reported p.Val50Met cases to examine the relationship between age at onset and amyloid detection in sural nerve biopsies.

The two patients carried the p.Val50Met and p.Glu74Gly variants in the TTR gene, respectively. Both presented with distal paresthesia as the initial symptom and exhibited length-dependent, axonal-predominant sensorimotor polyneuropathy. Autonomic manifestations included alternating diarrhea/constipation and post-exertional hyperhidrosis. Subclinical cardiac abnormalities were identified, encompassing elevated biomarker of early cardiac strain, valvular regurgitation, left ventricular hypertrophy, and late gadolinium enhancement. In patient 1, sural nerve pathology showed marked loss of myelinated and unmyelinated fibers with perivascular lymphocytic infiltration but no amyloid deposition. Logistic regression revealed no significant association between age at onset and biopsy amyloid positivity (p = 0.91).

This study expands the clinical and genetic landscape of ATTRv-PN in China and highlighted the heterogeneity of amyloid detection in nerve biopsies. Accurate and timely diagnosis requires an integrated approach combining clinical, electrophysiological, pathological, genetic, and multimodal imaging assessments to facilitate early initiation of disease-modifying therapies.

## Linked entities

- **Genes:** TTR (transthyretin) [NCBI Gene 7276]

## Full-text entities

- **Genes:** IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, IL7 (interleukin 7) [NCBI Gene 3574] {aka IL-7, IMD130}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, TTR (transthyretin) [NCBI Gene 7276] {aka AMYLD1, ATTR, CTS, CTS1, HEL111, HsT2651}, ALB (albumin) [NCBI Gene 280717], NFASC (neurofascin) [NCBI Gene 23114] {aka NEDCPMD, NF, NRCAML}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL33 (interleukin 33) [NCBI Gene 90865] {aka C9orf26, DVS27, IL1F11, NF-HEV, NFEHEV}, MB (myoglobin) [NCBI Gene 4151] {aka MYOSB, PVALB}, MB (myoglobin) [NCBI Gene 280695] {aka GLNG}, MBP (myelin basic protein) [NCBI Gene 4155]
- **Diseases:** lacunar infarcts (MESH:D059409), autonomic neuropathy (MESH:D009422), Hereditary transthyretin amyloidosis (MESH:C567782), atherosclerotic plaques (MESH:D058226), cardiac abnormalities (MESH:D018376), Amyloid (MESH:C000718787), constipation (MESH:D003248), cardiac complaints (MESH:D006331), liver dysfunction (MESH:D017093), peripheral neuropathy (MESH:D010523), paresthesia (MESH:D010292), gait impairment (MESH:D020234), neuropathic (MESH:D009437), infarcts (MESH:D007238), mitral and tricuspid regurgitation (MESH:D014262), axonal degeneration (MESH:D009410), ATTRv amyloidosis (MESH:D000686), venous thrombosis (MESH:D020246), myocardial involvement (MESH:C564676), numbness (MESH:D006987), post (MESH:D000094025), gastrointestinal disturbances (MESH:D005767), ischemic stroke (MESH:D002544), coldness (MESH:D000067390), ATTRv-PN (MESH:C565820), axonal or demyelinating neuropathies (MESH:D003711), left ventricular hypertrophy (MESH:D017379), systemic vasculopathy (MESH:C566007), amyloid toxicity (MESH:D017772), cerebellar or cranial nerve abnormalities (MESH:D003389), Autonomic dysfunction (MESH:D001342), fever (MESH:D005334), NCS (MESH:C537568), small-vessel cerebrovascular disease (MESH:D059345), diarrhea (MESH:D003967), cardiac strain (MESH:D013180), amyloid cardiomyopathy (MESH:D009202), multisystem disorder (MESH:D019578), diastolic dysfunction (MESH:D018487), ischemic white matter lesions (MESH:D056784), neuroinflammatory (MESH:D000090862), weakness (MESH:D018908), valvular regurgitation (MESH:D006349), polyneuropathy (MESH:D011115), diabetes mellitus (MESH:D003920), sensory disturbances (MESH:D012678), diminished pain sensation (MESH:D020886), FAP (MESH:D028227), exertional hyperhidrosis (MESH:D006945), systemic amyloidosis (MESH:D009101), pain (MESH:D010146), fiber neuropathy (MESH:D000071075), CIDP (MESH:D020277), vasculitis (MESH:D014657), inflammatory (MESH:D007249)
- **Chemicals:** formalin (MESH:D005557), eosin (MESH:D004801), glutaraldehyde (MESH:D005976), inotersen (MESH:C000629536), lipid (MESH:D008055), toluidine (MESH:D014052), gadolinium (MESH:D005682), Congo red (MESH:D003224), uranyl acetate (MESH:C005460), Tafamidis (MESH:C547076), hematoxylin (MESH:D006416), H&amp;E (MESH:D006371), 99mTc-PYP (-), Toluidine blue (MESH:D014048), methylene blue (MESH:D008751), polymer (MESH:D011108), osmium tetroxide (MESH:D009993)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** p.Glu74Gly, p.Glu74Gly, p.Val50Met

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960095/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12960095/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960095/full.md

---
Source: https://tomesphere.com/paper/PMC12960095